Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 5VCR | Q10469 | Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase with bound uranium dioxide | Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (E.C.2.4.1.143) |
| 5VCS | Q10469 | Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase with Bound Acceptor | |
| 5VDH | O75311 | Crystal Structure of Human Glycine Receptor alpha-3 Bound to AM-3607, Glycine, and Ivermectin | |
| 5VDN | Q8CZL0 | 1.55 Angstrom Resolution Crystal Structure of Glutathione Reductase from Yersinia pestis in Complex with FAD | |
| 5VEB | S6B291 | Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 | |
| 5VEB | 5VEB | Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 | |
| 5VEB | S6B291 | Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 | |
| 5VEB | 5VEB | Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 | |
| 5VEB | P01834 | Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 | |
| 5VEB | P01834 | Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 | |
| 5VEB | P55285 | Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 | |
| 5VEM | Q9UJA9 | Human ectonucleotide pyrophosphatase / phosphodiesterase 5 (ENPP5, NPP5) | Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E.C.3.1.-.-) |
| 5VEN | Q9EQG7 | Murine ectonucleotide pyrophosphatase / phosphodiesterase 5 (ENPP5, NPP5) | Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E.C.3.1.-.-) |
| 5VEO | Q9EQG7 | Murine ectonucleotide pyrophosphatase / phosphodiesterase 5 (ENPP5, NPP5), inactive (T72A), in complex with AMP | Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E.C.3.1.-.-) |
| 5VF2 | 5VF2 | scFv 2D10 re-refined as a complex with trehalose replacing the original alpha-1,6-mannobiose | |
| 5VGJ | 5VGJ | Crystal Structure of the Human Fab VRC38.01, an HIV-1 V1V2-Directed Neutralizing Antibody Isolated from Donor N90, bound to a scaffolded WITO V1V2 domain | |
| 5VGP | Q6PYX1 | Fc fragment of human IgG1 antibody, from NIST mAb | |
| 5VH5 | 5VH5 | Crystal Structure of Fc fragment of anti-TNFa antibody infliximab | |
| 5VHW | P19491 | GluA2-0xGSG1L bound to ZK | Glutamate receptor 2,Germ cell-specific gene 1-like protein |
| 5VHW | D3ZK93 | GluA2-0xGSG1L bound to ZK | Glutamate receptor 2,Germ cell-specific gene 1-like protein |
| 5VHX | P19491 | GluA2-1xGSG1L bound to ZK | Glutamate receptor 2,Germ cell-specific gene 1-like protein |
| 5VHX | D3ZK93 | GluA2-1xGSG1L bound to ZK | Glutamate receptor 2,Germ cell-specific gene 1-like protein |
| 5VHY | P19491 | GluA2-2xGSG1L bound to ZK | Glutamate receptor 2,Germ cell-specific gene 1-like protein |
| 5VHY | D3ZK93 | GluA2-2xGSG1L bound to ZK | Glutamate receptor 2,Germ cell-specific gene 1-like protein |
| 5VI4 | Q8BVZ5 | IL-33/ST2/IL-1RAcP ternary complex structure | |
| 5VI4 | P14719 | IL-33/ST2/IL-1RAcP ternary complex structure | |
| 5VI4 | Q61730 | IL-33/ST2/IL-1RAcP ternary complex structure | |
| 5VIE | O15294 | Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase | |
| 5VIE | 5VIE | Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase | |
| 5VIF | O15294 | Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase | |
| 5VIF | 5VIF | Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase | |
| 5VIY | Q2N0S6 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
| 5VIY | P01834 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
| 5VIY | 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
| 5VIY | P01834 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
| 5VIY | 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
| 5VIY | S6B291 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
| 5VIY | S6B291 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
| 5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
| 5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
| 5VJK | R4NN21 | Crystal structure of H7 hemagglutinin mutant (V186K, K193T, G228S) from the influenza virus A/Shanghai/2/2013 (H7N9) | |
| 5VJL | R4NN21 | Crystal structure of H7 hemagglutinin mutant (V186K, K193T, G228S) from the influenza virus A/Shanghai/2/2013 (H7N9) with LSTc | |
| 5VJM | R4NN21 | Crystal structure of H7 hemagglutinin mutant (V186K, K193T, G228S) from the influenza virus A/Shanghai/2/2013 (H7N9) with LSTa | |
| 5VK2 | P08669 | Structural basis for antibody-mediated neutralization of Lassa virus | |
| 5VK2 | 5VK2 | Structural basis for antibody-mediated neutralization of Lassa virus | |
| 5VKI | A7YCM0 | Crystal structure of P[19] rotavirus VP8* complexed with mucin core 2 | |
| 5VKJ | P20273 | Crystal structure of human CD22 Ig domains 1-3 | |
| 5VKM | P20273 | Crystal structure of human CD22 Ig domains 1-3 in complex with alpha 2-6 sialyllactose | |
| 5VKS | A7YCM0 | Crystal structure of P[19] rotavirus VP8* complexed with LNFPI | |
| 5VL3 | S6B291 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain |
